# Effect of Administering Intravenous Magnesium Sulfate on Fetal Cardiotocography and Neonatal Outcome in Preeclamptic Patients

> **NCT03237000** · PHASE4 · UNKNOWN · sponsor: **Cairo University** · enrollment: 100 (estimated)

## Conditions studied

- Preeclampsia

## Interventions

- **DRUG:** MgSO4

## Key facts

- **NCT ID:** NCT03237000
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-01
- **Primary completion:** 2017-12
- **Final completion:** 2018-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03237000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03237000, "Effect of Administering Intravenous Magnesium Sulfate on Fetal Cardiotocography and Neonatal Outcome in Preeclamptic Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03237000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*